Sara Tolaney

111PUBLICATIONS
595CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersInnate immunityEconomic models and forecasting
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (111)

|Oct 19, 2026
Paxalisib with Trastuzumab for HER2-Positive Metastatic Breast Cancer with Active Brain Metastases: A Phase II Trial with Integrated Plasma and CSF ctDNA Analyses.

|Oct 08, 2026
Right-sizing treatment for HER2-positive breast cancer: evolving algorithms across the disease continuum.

|Aug 24, 2026
Elacestrant in Combination with Everolimus for Estrogen Receptor-Positive, HER2-Negative Previously Treated Advanced Breast Cancer: Results from ELEVATE.

|Jul 30, 2026
Clinical toxicity of ADCs and ICI-ADC combinations: mechanisms, patterns and management.

|Jul 13, 2026
Avutometinib, Abemaciclib, and Fulvestrant in Patients with HR+/HER2- Metastatic Breast Cancer Previously Treated with CDK4/6 Inhibitor: A Single-Arm Phase I Trial.

|Jun 05, 2026
Longitudinal multi-platform profiling reveals temporal dynamics of HER2, TROP2, PD-L1 and tumor-infiltrating lymphocytes in triple-negative breast cancer.

Pageof 19

Frequent Collaborators

18 joint publications

Paolo Tarantino

17 joint publications

Ann Partridge

16 joint publications

Hope S Rugo

16 joint publications

Nabihah Tayob